2 not yet recruiting, 1 active not recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 2, Active not recruiting 1 |
Follow Patient Preference: new trials by email Literature Review of Patient Preference trials Research Report on Patient Preference
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Patient Choice Between Antibiotics and Appendectomy in Uncomplicated Appendicitis (FRENCH 47 - ALACARTE) Shared decision-making, amoxicillin-clavulanate, Appendectomy - Acute Appendicitis | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 560 | 2026-10-01 | 2026-10-05 |
| Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy Psilocybin 25mg, Music-centered psilocybin-assisted therapy, Mindfulness-centered psilocybin-assisted therapy - Treatment-Resistant Major Depressive Disorder | Phase 2 | Not yet recruiting | Kyle Greenway | 16 | 2026-05-01 | 2026-04-22 |
| A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations relatlimab+nivolumab, relatlimab+nivolumab+rHuPH20, nivolumab - Melanoma | Phase 2 | Active not recruiting | Bristol-Myers Squibb | 100 | 2023-11-06 | 2026-09-14 |
Appendicitis (1) · Depressive Disorder, Treatment-Resistant (1) · Melanoma (1) · Neoplasm Metastasis (1)
Behavior (3) · Health Behavior (3) · Patient Satisfaction (3) · Treatment Adherence and Compliance (3) · Cecal Diseases (1) · Depressive Disorder (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Infections (1) · Intestinal Diseases (1) · Intraabdominal Infections (1) · Mental Disorders (1) · Mood Disorders (1) · Neoplasms (1)
Amoxicillin-Potassium Clavulanate Combination (1) · Appendectomy (1) · Nivolumab (1) · Opdualag (1) · Psilocybin (1)
Assistance Publique - Hôpitaux de Paris (1) · Bristol-Myers Squibb (1) · Kyle Greenway (1)
Canada (1) · Chile (1) · France (1) · Greece (1) · Italy (1) · Spain (1) · United States (1)
2023 (1), 2025 (1)